Top-Thema

20.11.17
ROUNDUP: AT&T wehrt sich gegen US-​Kartellklage wegen Time-​Warner-Übernahme

Boston Scientific to Participate in 2017 RBC Capital Markets Global Healthcare Conference

Mittwoch, 15.02.2017 14:35 von PR Newswire

PR Newswire

MARLBOROUGH, Mass., Feb. 15, 2017 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 2017 RBC Capital Markets Global Healthcare Conference on Thursday, February 23, 2017 in New York.

Dan Brennan, executive vice president and chief financial officer, and Susie Lisa, vice president, Investor Relations, will participate in a 30-minute question-and-answer-session with the host analyst beginning at approximately 8:00 a.m.

A live webcast of the question-and-answer-session will be available on the Investor Relations section of the Boston Scientific website at www.bostonscientific.com/investors. We encourage interested parties to register at least 15 minutes prior to the scheduled start time to ensure a timely connection.

A replay of the webcast will be accessible at www.bostonscientific.com/investors beginning approximately one hour following the completion of the event.

About Boston Scientific 
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world.  As a global medical technology leader for more than 35 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare.  For more information, visit www.bostonscientific.com and connect on Twitter and Facebook.

CONTACTS


Media:

Investors:

Tom Keppeler

Susie Lisa, CFA

508-683-6585 (office)

508- 683-5565 (office)

Media Relations

Investor Relations

Boston Scientific Corporation

Boston Scientific Corporation

thomas.keppeler@bsci.com 

investor_relations@bsci.com

 

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/boston-scientific-to-participate-in-2017-rbc-capital-markets-global-healthcare-conference-300407622.html

SOURCE Boston Scientific Corporation